Resero Analytics returns to the European Congress of Toxicologic Pathology (ESTP), held jointly with the British Society of Toxicologic Pathology (BSTP), from September 23–26, 2025, in Manchester, UK, with new AI-powered tools that enhance toxicologic pathology and regulatory workflows.

TurboChat: Unlocking Drug Safety Insights with AI

Join us on September 24 at 08:15 AM for a sponsored session titled TurboChat: Unlocking Drug Safety Insights with AI. Product Manager Taylor Scott will demonstrate how AI can help toxicologic pathologists rapidly compare their study findings to decades of FDA drug approval data and thereby interpret the relevance of new histopathology findings.

What is TurboChat?

TurboChat is a new AI-enabled feature in Resero’s Turbo Platform that helps toxicologic pathologists interpret study findings with unprecedented speed and clarity. Drawing from over 40 years of data extracted from FDA pharmacology reviews, TurboChat enables scientists to:

• Identify FDA-approved drugs that produced similar pathology findings
• Compare exposure multiples (dose, Cmax, AUC) between animals and humans at MRHD
• Assess severity, incidence, and recover in preclinical studies
• Evaluate whether pathology findings translated to human outcomes
• Click directly to source data in FDA Pharmacology Reviews and drug labels

Pathologists interact dynamically in chat format. TurboChat responds by presenting data as free text, bullet points, and structured data tables. Each table highlights matched compounds, relevant study conditions, and hyperlinks to the precise pages in FDA source documents.

This integration of AI and regulatory data empowers scientists to answer key questions:

• Have similar findings been accepted by the FDA?
• Were they observed at higher or lower exposure multiples?
• Did they translate to clinical outcomes in humans?

By placing new data the context of prior FDA approvals, TurboChat reduces uncertainty and supports faster, more confident decision-making in nonclinical safety assessment.

TurboToxicology: Efficiency Meets Regulatory Intelligence

TurboToxicology, the foundation of TurboChat, automates data review, interpretation, and report generation, enabling faster, more informed decisions in nonclinical development. It supports:

• Structured, submission-ready reports for toxicologic pathology
• Integrated LLM-driven text generation
• Streamlined review of complex pathology findings

Resero’s platform reduces time spent on manual tasks and increases clarity around regulatory relevance. The software is actively used to support decision-making in nonclinical safety assessment.

At the 2024 ESTP Congress in Spain, Resero presented Harnessing AI: TurboToxicology Integrates Cutting-Edge LLMs for Enhanced Reporting of Pathology and Toxicology Study Data. That presentation, which demonstrated large language model (LLM) use for regulatory text generation, received strong engagement from attendees. The 2025 presentation builds on that foundation and introduces a broader decision-support framework with TurboChat.

Meet the Team at ESTP 2025

Visit the Resero Analytics booth to explore AI-powered tools for toxicology. Meet:

• Taylor Scott, Product Manager
• Dave Watson, Ph.D., Founder and CEO
• Maureen Lynch, Head of Commercial

To explore how Resero’s AI-powered tools can support your organization’s toxicology workflows, visit the Resero Analytics booth at ESTP 2025.

To schedule a demo or meeting in advance, contact the team directly or submit an inquiry on our website.